In order to make spatial inferences about the brain across a group of patients, it is usually necessary to employ some means of bringing each brain image into register with either a group mean image or a standard template. In the presence of focal brain lesions, automated methods for performing such so-called normalization are liable to distortion from the abnormal signal within the lesion, especially when the non-linear warping necessary for maximum registration fidelity is used. The most frequently used method for minimizing this distortion--cost function masking--simply eliminates the lesioned area when deriving the normalization parameters. As lesion size increases, however, the normalization error may be expected to rise steeply since the volume of brain from which the parameters are derived falls with it. Here we propose an alternative non-linear registration method that exploits a natural redundancy in the brain--the enantiomorphic relation between the two hemispheres--to correct the signal within the lesion using information from the undamaged homologous region within the contralesional hemisphere. As lesion size increases, the normalization error should theoretically asymptote to inter-hemispheric differences, which are both quantifiable and much lower than the inter-subject difference. Using SPM's non-linear normalization routines, we evaluate this technique with images of normal brains to which lesions selected from a large dataset have been artificially applied. Our results show the enantiomorphic method to be vastly superior to cost function masking across subjects, lesion characteristics, and brain voxels. We therefore propose that it should be the method of choice for normalizing images of focally lesioned brains.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658465PMC
http://dx.doi.org/10.1016/j.neuroimage.2007.10.002DOI Listing

Publication Analysis

Top Keywords

focally lesioned
8
lesioned brains
8
signal lesion
8
lesion size
8
size increases
8
increases normalization
8
normalization error
8
brain
5
normalization
5
lesion
5

Similar Publications

Functional Regrowth of Norepinephrine Axons in the Adult Mouse Brain Following Injury.

eNeuro

December 2024

Solomon H. Snyder Department of Neuroscience, The Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, MD 21205, USA.

It is widely believed that axons in the central nervous system of adult mammals do not regrow following injury. This failure is thought, at least in part, to underlie the limited recovery of function following injury to the brain or spinal cord. Some studies of fixed tissue have suggested that, counter to dogma, norepinephrine (NE) axons regrow following brain injury.

View Article and Find Full Text PDF

Objective: This study aims to investigate the feasibility of employing artificial intelligence models for the detection and localization of cervical lesions by leveraging deep semantic features extracted from colposcopic images.

Methods: The study employed a segmentation-based deep learning architecture, utilizing a deep decoding network to integrate prior features and establish a semantic segmentation model capable of distinguishing normal and pathological changes. A two-stage decision model is proposed for deep semantic feature mining, which combines image segmentation and classification to categorize pathological changes present in the dataset.

View Article and Find Full Text PDF
Article Synopsis
  • Spiral ganglion neuron (SGN) degeneration may lead to poorer hearing outcomes in cochlear implant (CI) users, but there's no existing method to locate these degenerated areas in patients.
  • Research on guinea pigs showed that small cochlear micro-lesions significantly increased electrical thresholds and lowered eCAP amplitudes, with effects noticeable up to 3.5 mm away from the lesions.
  • A new electrophysiological marker called the Failure Index (FI) was developed, which accurately indicates the presence and proximity of SGN degeneration and demonstrates a high classification accuracy in identifying affected areas, making it a promising tool for clinical applications.
View Article and Find Full Text PDF
Article Synopsis
  • - Parkinson's disease involves the loss of dopamine-producing neurons, leading to disrupted brain circuitry that negatively impacts both cognitive function and decision-making behavior due to elevated glutamate levels.
  • - The study investigates GTS467, a drug that activates an important transporter responsible for clearing excess glutamate, hypothesizing it could mitigate cognitive deficits without increasing impulsivity in PD patients.
  • - Chronic treatment with GTS467 in rat models showed improved task performance and reduced impulsive actions, alongside beneficial changes in glutamate levels and gene expression related to brain health, supporting its potential as a therapeutic option for PD.
View Article and Find Full Text PDF

Background: L-DOPA has been considered the first-line therapy for treating Parkinson's disease (PD) via restoring striatal dopamine (DA) to normalize the activity of local spiny projection neurons (SPNs) in the direct (dSPNs) pathway and the indirect (iSPNs) pathway. While the changes in striatal acetylcholine (ACh) induced by increasing DA have been extensively discussed, their validity remains controversial. Inhibition of striatal cholinergic signaling attenuates PD motor deficits.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!